HBM Healthcare Investments — Full Portfolio

ALX Oncology develops therapies for cancer treatment, operating in the biotechnology and medical technology sectors.

BiotechHealthtechMedical Devices

CGCorey Goodman(Chairman)inJLJason Lettmann(Chief Executive Officer)in

Co-investorsLILightstone VenturesAGage1FOForesite CapitalHBHBM PartnersVEvenBio PartnersLOLogos+1 more

Freenome develops early-stage cancer detection technology using blood tests to identify cancer in its earliest, most treatable phases.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesLondon, US

RERiley Ennis(Founder)inCharles Roberts(Founder)inGOGabriel Otte(Founder)inAdam Stone(Chief Executive Officer and Director)Michael Altman(Chief Business Officer and Director)Shmuel (Sam) M. Cohn(Chief Financial Officer)

Co-investorsRARA CapitalAGAgent CapitalAMAME Cloud VenturesANAndreessen HorowitzARArtis VenturesASAsset Management Company+15 more

Harmony Biosciences develops innovative therapeutic treatments focused on rare neurological diseases.

BiotechHealthtechMedical DevicesNorthbrook, US

JAJeffrey Aronin(Director)inJMJeffrey M. Dayno, M.D.(President and Chief Executive Officer)inPatrick Morris(Secretary and Treasurer)inRobert Repella(Director and Chief Executive Officer)Darien Parhad(Chief Financial Officer)

BoardARAaron Royston(Director)in

Co-investorsAIAisling CapitalHBHBM PartnersPAParagon Biosciences LLCPIPivotal Life SciencesVAValor Equity PartnersVEvenBio Partners+3 more

Mineralys Therapeutics is a clinical-stage pharmaceutical company developing lorundrostat, a treatment targeting dysregulated aldosterone.

BiotechHealthtechRadnor, US

Eric Warren(Chief Commercial Officer)inAGAlex Gold(Chief Medical Officer)inAdam Levy(Executive Officer)Alexander Asam(Director)

BoardBrian Taylor Slingsby(Founder & former CEO / Board Director)OLOlivier Litzka(Director)in

Co-investorsANAndera PartnersHBHBM PartnersSASamsara BioCapitalSRSR One Capital ManagementYSYsios CapitalADAdams Street Partners+3 more

Monte Rosa develops molecular glue degrader (MGD) therapeutics using MGD chemistry, artificial intelligence, structural biology, and proteomics to target previously undruggable or inadequately drugged disease targets.

AI & Machine LearningBiotechDeep TechHealthtechBoston, US

MWMarkus Warmuth(M.D., Chief Executive Officer)inSTSharon Townson(Ph.D., Chief Scientific Officer)inJCJohn Castle(Ph.D., Chief Data and Information Officer)inFilip Janku(M.D., Ph.D., Chief Medical Officer)inPNPhil Nickson(Ph.D., J.D., Chief Business and Legal Officer)inMWMagnus Walter(DPhil, Chief Technology Officer)in

Co-investorsAIAisling CapitalHBHBM PartnersNENew Enterprise Associates (NEA)VEVersant VenturesAMAmzak HealthAVAvoro Capital Advisors+4 more

Natera develops genetic tests and diagnostics using cell-free DNA technology to detect diseases including cancers, genetic disorders, and transplant-related conditions.

BiotechDigital HealthHealthtechMedical Devices

MRMatthew Rabinowitz(Co-founder & Executive Chairman)inJonathan Sheena(Founder)inSteven Chapman(Chief Executive Officer & President)

Co-investorsBABain Capital Life SciencesCHCheyenne VenturesCLClaremont Creek VenturesFOForesite CapitalHAHarmony PartnersLILightspeed Venture Partners+4 more

Helicons develops a peptide-based therapeutic platform designed to target intracellular proteins previously considered undruggable by combining the specificity of antibodies with the cell-penetrating properties of small molecules.

AI & Machine LearningBiotechDeep TechMedical Devices

MMMathai Mammen(CEO, President and Chairman)in

Co-investorsARARCH Venture PartnersCACatalio Capital Management, LPFOForesite CapitalFRFrazier Life SciencesGEGeneral CatalystGVGV (Google Ventures)+9 more

Upstream Bio is a biotechnology company that sponsors clinical trials to develop products under investigation.

BiotechHealthtechWaltham, US

Rand Sutherland(Chief Executive Officer)inAAAllison Ambrose(General Counsel)inADAaron Deykin(Chief Medical Officer & Head of R&D)inMike Gray(Chief Financial Officer and Chief Operating Officer)AHAdam Houghton(Chief Business Officer)inStacy Price(Chief Technology Officer)in

Co-investorsOROrbiMedACAccess IndustriesACAccess BiotechnologyBABain Capital Life SciencesDEDecheng CapitalHBHBM Partners+5 more

Zymeworks is a biotechnology company that develops novel therapeutics for patients with difficult-to-treat diseases using its proprietary drug-development platforms and in-house R&D.

BiotechHealthtechVancouver, US

ATALI TEHRANI(Executive Officer, Director)inGORDON NG(Executive Officer)NKNEIL KLOMPAS(Executive Officer)inSDSURJIT DIXIT(Executive Officer)inDAVID TUCKER(Executive Officer)Paul Moore(Chief Scientific Officer)in

Co-investorsBRBrace PharmaCTCTI Life Sciences Fund L.P.LULumira VenturesNENextech InvestWUWUTIF CapitalAMAmplitude Venture Capital

1000Farmacie is an Italian online pharmacy and parapharmacy marketplace that aggregates products from over 60 partner pharmacies and other sellers, offering over 100,000 products for health and wellness including pharmaceuticals, medical devices, veterinary medicines, homeopathic and ayurvedic products, with home delivery across Italy.

B2B MarketplacesE-commerceHealthtechItaly, IT

NPNicolo Petrone(Founder)inAMAlberto Marchetti(Founder)in

Co-investorsCLClub degli InvestitoriHBHBM PartnersITItalian Angels for GrowthLILIFTTP1P101 Ventures

This is a product listing page on an online pharmacy for Tugain Twins 5 Solution, a topical minoxidil-based medicine sold to treat hair loss and promote hair regrowth.

Digital HealthE-commerceHealthtechIndia, IN

Gaurav Agarwal(Founder)Prashant Tandon(Founder)Vikas Chauhan(Founder)

Co-investorsHBHBM PartnersKAKae CapitalLELeo Capital VenturesPEPeak XV PartnersSPSpring Marketing CapitalVEVenturEast+3 more

AdrenoMed AG is a clinical-stage biopharmaceutical company developing Enibarcimab (formerly Adrecizumab), a first-in-class antibody targeting the peptide Adrenomedullin to restore vascular integrity in critically ill patients, with septic shock as its lead indication.

BiotechHealthtechMedical DevicesHennigsdorf, DE

Gerald Moeller(Co-founder and former CEO of AdrenoMed; Supervisory Board member)inRJRichard Jones(Chief Executive Officer (CEO))inDavid Germonpré(Chief Financial Officer (CFO))in

Co-investorsBRBrandenburg KapitalCACatalyze CapitalHBHBM PartnersVUVU Venture Partners

Amphora provides logistics services aimed at supporting business growth and operational efficiency.

E-commerceLogistics & Supply ChainSaaS

Joan Tresserras(Founder)inACAdrià Cortés(Founder)in

Co-investorsBSBStartupLOLongitude CapitalBABaird CapitalF-F-Prime Capital

Antiva Biosciences develops a topical therapeutic for women with high-risk HPV infection and pre-cancerous cervical lesions, utilizing antiviral prodrug chemistry.

BiotechFemTechHealthtechMedical DevicesRedwood City, US

KYKarl Y. Hostetler(Executive Officer, Director)inGMGail Maderis(Director)inKBKristine Ball(President & CEO)inECElaine Chien(Executive Officer)inSarah Walter(Executive Officer)inRGRaju Gadiraju(Executive Officer)in

Co-investorsADAdjuvant CapitalAVAvestria VenturesBRBrace PharmaCACanaan PartnersGAGaingelsGVGV (Google Ventures)+6 more

BiotechEvanston, US

Joseph R. Moskal(Chief Scientific Officer)Torsten M. Madsen(Chief Marketing Officer)Ashish Khanna(Secretary & Chief Business Officer)Norbert G. Riedel(Chief Executive Officer)

BoardLiam Ratcliffe(Director)Terry P. Gould(Director)

Co-investorsBABain Capital Life SciencesFRFrazier Life SciencesLALatterell Venture PartnersLOLongitude CapitalOUOUP (Osage University Partners)AGAgent Capital+3 more

The company develops therapies for people with severe autoimmune diseases.

BiotechHealthtechMedical Devices

Co-investorsAVAvoro Capital AdvisorsBIBioGeneration VenturesMPMPM BioImpactPMPMVSESeventure PartnersAEAescap Life Sciences+2 more

Arrakis Therapeutics develops RNA-targeted small-molecule (rSM) medicines, working independently and with partners to create drug candidates aimed at the root causes of disease.

AI & Machine LearningBiotechDeep TechHealthtechCambridge, US

MGMichael Gilman(Executive Officer, Director)inMDMark DeLong(CEO)inDNDavid Neafus(Executive Officer)inRussell C. Petter(Executive Officer)

BoardCCColleen Cuffaro(Director)inAEAlan E. Walts(Director)in

Co-investorsCACanaan PartnersPFPfizer VenturesADAdvent Life SciencesHBHBM PartnersNENextech InvestOUOUP (Osage University Partners)+2 more

ArriVent BioPharma is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing medicines for difficult-to-treat diseases, starting with cancers.

BiotechHealthtechMedical DevicesNewtown Square, US

Z(Zhengbin (Bing) Yao(Executive Officer, Director)inBRBrent Rice(Chief Commercial Officer)in

BoardJason Zhang(Director)Cong Xu(Director)Stuart Lutzker(Director)

Co-investorsCACatalio Capital Management, LPFOForesite CapitalGEGeneral CatalystHBHBM PartnersHOHongShan Capital GroupLALAV+4 more

BioAtla develops novel monoclonal antibody and cell-based therapeutics for cancer treatment using proprietary platforms including Conditionally Active Biologics (CAB) and Comprehensive Integrated Antibody Optimization (CIAO!).

BiotechHealthtechMedical DevicesSan Diego, US

JMJay M. Short(Executive Officer, Director)RARichard A. Waldron(Executive Officer)inCarolyn Short(Director)

Co-investorsKEKeshif VenturesPAPappas CapitalPFPfizer Venture InvestmentsPAPappas CapitalPFPfizer VenturesSOSoleus Capital

Biohaven is a biopharmaceutical company that discovers, develops, and commercializes treatments across immunology, obesity, neuroscience, and oncology, targeting rare and common diseases with limited treatment options.

BiotechHealthtech

VCVlad Coric(Chairman & Chief Executive Officer)in

Co-investorsAIAisling CapitalAPAPERTURE Venture PartnersCOConnecticut InnovationsOUOUP (Osage University Partners)OROrbiMed

Bluejay is a biotechnology company focused on therapeutic development.

BiotechSan Mateo, US

KCKeting Chu(Founder, Chief Executive Officer and Chairman of the Board)inDajun Yang(Director)Nancy Hong(Director)inAlon Lazarus(Director)William J. Rutter(Director)Ting Jia(Director)

Co-investorsFRFrazier Life SciencesRARA CapitalRIRiverVest Venture PartnersWEWellington ManagementFRFrazier Healthcare PartnersNONovo Holdings+2 more

CellCentric develops inobrodib, a small-molecule oral p300/CBP inhibitor intended to treat multiple myeloma and other cancers.

BiotechHealthtechMedical Devices

Azim Surani(Co-founder)

Co-investorsAVAvego BioScience CapitalFUFuture Planet CapitalHBHBM PartnersRARA CapitalSOSofinnova PartnersBRBrightEdge+3 more

connectRN operates a mobile app marketplace that matches nurses and clinicians with open shifts at healthcare facilities such as hospitals, home health, and hospice across the US.

Future of WorkHealthtechHR TechMarketplacesWaltham, US

TJTed Jeanloz(Executive Officer)in

BoardMichael Jasulavic(Director)John Pappajohn(Director)Geoffrey Harris(Director)Idriz Limaj(Director)

Co-investorsDAData Point CapitalHBHBM Partners

Develops therapies for cardiometabolic conditions.

Co-investorsNENew Enterprise Associates (NEA)RARA CapitalRTRTW Investments L.P.

Curevo Vaccine is a biotech company developing next-generation non-mRNA vaccines, with a focus on infectious diseases.

BiotechHealthtech

GSGeorge Simeon(CEO)inGregory S. Curhan(CFO)GDGuy De La Rosa(CMO)in

Co-investorsADAdjuvant CapitalOROrbiMedRARA CapitalSASanofi VenturesJAJanus Henderson InvestorsMEMedicxi

Dren Bio is a clinical-stage biopharmaceutical company developing novel antibody therapeutics designed to selectively eliminate pathogenic cells and disease-causing agents, with a pipeline targeting oncology, autoimmune diseases, immunology, and neurology.

BiotechHealthtechMedical DevicesFoster City, US

NTNenad Tomasevic(Founder)

BoardIvan Trifunovich(Director)John Wesley(Founder)

Co-investors8V8VCAIAisling CapitalHBHBM PartnersJAJacket River Capital PartnersMIMission Bay CapitalMIMission Biocapital+5 more

Biotechnology company using multiplex gene editing to develop genetically engineered porcine organs for human transplantation.

BiotechBrookline, US

Luhan Yang(President, Secretary and Treasurer)Geoff MacKay(Chief Executive Officer)

BoardGMGeorge M. Church(Director)

Co-investorsALAlta PartnersARARCH Venture PartnersCACatalio Capital Management, LPHBHBM PartnersKHKhosla VenturesLILifeSci Venture Partners+12 more

Electra Therapeutics develops antibody therapeutics targeting Signal Regulatory Protein (SIRP) for immunological diseases and cancer treatment.

BiotechHealthtechMedical DevicesSouth San Francisco, US

ARAdam Rosenthal(Co-founder and former CEO; Director)inQuehuong (Kathy) Dong, Pharm.D.(Executive Officer, Director)Kathy Dong(President, Chief Executive Officer and Director)in

BoardBeth Seidenberg, M.D.(Director)Thomas Geninatti, Ph.D.(Director)Carl Gordon, Ph.D.(Director)

Co-investorsHBHBM PartnersOROrbiMedRARA CapitalWEWestlake Village BioPartnersKLKleiner PerkinsNVNVIDIA

Fore Biotherapeutics is a clinical-stage oncology company developing targeted cancer therapies, including its lead plixorafenib program.

BiotechHealthtechMedical DevicesPhiladelphia, US

Co-investorsHBHBM PartnersLGLG Technology VenturesNONovartis Venture FundOROrbiMedPOPontifax Venture CapitalSRSR One Capital Management+4 more

Genalyte develops Merlin, a real-time diagnostic system that performs laboratory testing directly in clinical settings and integrates results with electronic health records.

Digital HealthHardwareHealthtechMedical DevicesSan Diego, US

CGCary Gunn(Founder)in

Co-investorsBIBioBritBOBoutique Venture PartnersCLClaremont Creek VenturesCLCLI VenturesFUFusionX VenturesHBHBM Partners+7 more

Clinical-stage genetic medicines company using human-derived AAV vectors and nuclease-free gene editing for rare diseases.

BiotechBedford, US

Siyamak Rasty(Executive Officer)Albert Seymour(Executive Officer)

BoardSteven Gillis(Director)ATArthur Tzianabos(Executive Officer, Director)KPKush Parmar(Director)inRichard Gregory(Director)

Co-investors5A5AM VenturesARARCH Venture PartnersOUOUP (Osage University Partners)ALAlexandriaDEDeerfield Management CompanyFIFidelity Investments+5 more

IOBiotech appears to be a biotech company focused on oncology, with a founder who has extensive experience in cancer drug development and clinical advancement from roles at Roche, Eli Lilly, and leading academic cancer centers.

BiotechMedical Devices

Dr. Dhingra

Co-investorsAVAvoro Capital AdvisorsEIEIR VenturesKUKurma PartnersPIPivotal Life SciencesRARA CapitalSASamsara BioCapital+3 more

Karius is a company that provides microbial cell-free DNA (mcfDNA) metagenomic sequencing services for research and clinical applications.

AI & Machine LearningBiotechDigital HealthMedical DevicesSan Francisco, US

AFAlec Ford(Chief Executive Officer)inMickey Kertesz(Founder)Stephen Quake(Founder)Tim Blauwkamp(Founder)

Co-investors5A5AM VenturesDCDCVC (Data Collective)HBHBM PartnersKHKhosla VenturesLILightspeed Venture PartnersSESeventure Partners+3 more

Lycia Therapeutics is a biotechnology company developing LYTAC (Lysosomal Targeting Chimera) therapeutics that bind disease-causing extracellular and cell-surface proteins and route them into the cell's lysosome for degradation.

BiotechHealthtechSouth San Francisco, US

CBCarolyn Bertozzi(Lycia founder and Professor of Chemistry, Stanford University)inAWAetna Wun Trombley(President and CEO)inABAmy Bachrodt(Chief Financial Officer)inCLChin Lee(Chief Medical Officer)inSSSteve Staben(Chief Scientific Officer)inSTSofia Touami(Chief Business Officer)in

Co-investorsREREDMILEVEVersant VenturesHBHBM PartnersBABAM ElevateFRFranklin TempletonINInvus+5 more

Mahzi develops therapies for patients with under-diagnosed and under-served rare genetic neurodevelopmental disorders, working with patient and family groups, academic researchers, and industry partners.

BiotechHealthtechSouth San Francisco, US

YWYael Weiss(Founder)in

BoardCSCamille Samuels(Director)inMSMarten Steen(Director)inSSShalini Sharp(Director)inStephen Farr(Director)

Co-investorsDRDroia VenturesHBHBM PartnersHEHealthCapMIMitsui Global InvestmentVEVenrock

Neurelis is a neuroscience-based biopharmaceutical company that develops treatments for people living with neurological conditions such as epilepsy.

BiotechHealthtechMedical DevicesEncinitas, US

CCCraig Chambliss(Founder)in

BoardDavid F. Hale(Director)Cam Garner(Director)Yong Zhang(Director)KLKevin Li(Director)in

Co-investorsHBHBM PartnersLYLYZZ CapitalOROrbiMed

Neuron23 is a biotech company using data science, human genetics, and functional genomics to develop precision medicines and companion diagnostics for neurodegenerative diseases, starting with an LRRK2 program for Parkinson's disease.

AI & Machine LearningBiotechDeep TechDigital HealthSouth San Francisco, US

NSNancy Stagliano(CEO)in

Co-investorsHBHBM PartnersKLKleiner PerkinsSOSoftBank GroupSOSoftBank Vision FundWEWestlake Village BioPartnersACACORN BIOVENTURES+2 more

NiKang Therapeutics is a clinical-stage biotechnology company developing small molecule drugs for cancer, using structure-based drug design against targets such as HIF2α, CDK2, KRAS, and SHP2.

BiotechHealthtechWilmington, CN

Yan Lou(Founder)inZhenhai Gao(President, CEO, and Secretary)H(Hong (Kelsey) Chen(Chief Financial Officer)

BoardGary Yeung(Director)Ting Jia(Director)Roderick Wong(Director)

Co-investorsECEcoR1 CapitalHBHBM PartnersLALAVLILilly Asia VenturesRARA CapitalSASamsara BioCapital+3 more

Numab develops multispecific antibody-based therapeutics using its proprietary λ-Cap and MATCH discovery and engineering platforms, aiming to improve on first-generation antibody therapies in potency, stability, effect duration, and safety.

BiotechDeep Tech

DUDavid Urech(Founder)in

Co-investorsEIEisai Innovation, Inc.HBHBM PartnersBIBiotechnology Value FundBLBlackRockFOForbionNONovo Holdings+1 more

Shape Memory Medical develops embolization and occlusion medical devices built on a bioabsorbable shape memory ("smart") polymer that expands to conform to vascular anatomy.

HealthtechSan Jose, US

Duncan Maitland(Director)inMichael Henson(Executive Officer, Director)inEdward F. Ruppel, Jr(Executive Officer, Director)Carolyn M. Bruguera(Executive Officer)JYJames Y Lancaster(Executive Officer, Director)in

BoardThom Rasche(Director)

Co-investorsEMEmergent Medical Partners, LLPHBHBM PartnersEAEarlybird Venture CapitalTATaiwania Capital

SphingoTec develops proprietary biomarkers for critical care diagnostics, addressing acute kidney injury, sepsis, and acute heart failure through partnerships with in vitro diagnostics companies and pharmaceutical firms.

BiotechDeep TechDigital HealthHealthtechMedical DevicesHennigsdorf, DE

DBDeborah Bergmann(Chief Executive Officer)in

Co-investorsBRBrandenburg KapitalHBHBM Partners

Swixx BioPharma is a specialized pharmaceutical distributor and market access partner that represents international biopharma, OTC, and medical device companies in markets across Central & Eastern Europe, the Middle East, North Africa, Latin America, and Eurasia.

BiotechHealthtechMedical DevicesBaar, CH

Co-investorsBABain Capital Life SciencesHBHBM PartnersMÉMérieux Equity PartnersSKSK Capital Partners

Valo Health applies technology and data to drug discovery, working across the technology, biotech, and healthcare fields.

AI & Machine LearningBiotechHealthtech

DBDavid Berry(Founder)in

Co-investorsATAtinum Investment Co. Ltd.BIBioGenerator VenturesFLFlagship PioneeringHBHBM PartnersKOKoch Disruptive TechnologiesWEWestern Technology Investment